Bariatric Medicine Institute, 1046 E 100 S, Salt Lake City, UT, 84102, USA.
Lenox Hill Hospital, New York, NY, USA.
Obes Surg. 2020 Apr;30(4):1506-1514. doi: 10.1007/s11695-019-04352-y.
Single-anastomosis duodenal switch has been suggested to be an effective bariatric procedure that offers excellent weight loss and by lengthening the common channel the potential to reduce micronutrient deficiencies.
To evaluate the weight loss, comorbidity resolution and the 1-year nutritional outcomes of the single-anastomosis duodenal switch (SADS) procedure.
Multiple US Hospitals.
From October 2014 to January 2017, 120 patients were enrolled at six sites across the USA and underwent the SADS procedure. Weight loss, comorbidities, quality of life, and adverse events were followed post-procedure for 12 months.
At 1, 6, and 12 months, 98.3%, 85.5%, and 77.1% of the patients were available for assessment, respectively. At 12 months, patients showed significantly reduced body mass index when compared to baseline (46.8 ± 5.8 vs 29.8 ± 4.4, P < 0.001 respectively). Sixty-five patients had type 2 diabetes at baseline; however, 11 patients lost to follow-up. Of the available data (54 patients), 96.3% of the patients had a resolution of type 2 diabetes by 12 months with a mean A1C reduction from 7.8 ± 1.6 to 5.3 ± 0.7. Additionally, there were reductions in hyperlipidemia, sleep apnea, and hypertension at 12 months. Patient gastroesophageal reflux disease satisfaction and quality of life (SF-36) scores were significantly higher at 12 months post-procedure (P < 0.001 in all cases) while 12-month protein levels remained at normal values. There were abnormalities of parathyroid hormone and vitamin D at 1 year with all other nutritional markers being not significantly different at 1 year from baseline. There were 10, IIIb, or greater complications according to the Clavien-Dindo scoring system during the study period, not all of which were related to the surgery.
SADS is a highly efficacious weight loss procedure with significant comorbidity reduction at 1 year. At 1 year, complications and vitamin and mineral deficits appear to be consistent with other malabsorption operations. Long-term follow-up is needed, especially around complications and vitamin deficiencies.
单吻合口十二指肠转流术(SADS)被认为是一种有效的减肥手术,它不仅能提供极好的减重效果,而且通过延长共同通道,还有可能减少微量营养素缺乏。
评估单吻合口十二指肠转流术(SADS)的减重效果、合并症缓解情况和 1 年的营养结局。
美国多家医院。
2014 年 10 月至 2017 年 1 月,美国 6 个地点的 120 名患者入组,并接受 SADS 手术。术后 12 个月对体重减轻、合并症、生活质量和不良事件进行随访。
在 1、6 和 12 个月时,分别有 98.3%、85.5%和 77.1%的患者可用于评估。与基线相比,12 个月时患者的体重指数显著降低(分别为 46.8±5.8 比 29.8±4.4,P<0.001)。基线时有 65 名患者患有 2 型糖尿病,但 11 名患者失访。在可获得数据的(54 名患者)中,96.3%的患者在 12 个月时糖尿病得到缓解,平均糖化血红蛋白从 7.8±1.6 降至 5.3±0.7。此外,在 12 个月时,高血脂、睡眠呼吸暂停和高血压也有所减轻。患者胃食管反流病满意度和生活质量(SF-36)评分在术后 12 个月显著升高(所有病例均 P<0.001),而 12 个月时的蛋白质水平仍处于正常值。在 1 年时,甲状旁腺激素和维生素 D 水平出现异常,而其他所有营养标志物与基线相比在 1 年时均无显著差异。根据 Clavien-Dindo 评分系统,在研究期间有 10 例、Ⅲb 级或更高级别的并发症,并非所有并发症都与手术有关。
SADS 是一种高效的减肥手术,在 1 年内显著降低合并症。在 1 年时,并发症和维生素及矿物质缺乏似乎与其他吸收不良手术一致。需要长期随访,特别是要关注并发症和维生素缺乏。